MA38162A1 - Pastille medicamenteuse a base d'ibuprofene sodique dihydrate - Google Patents

Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Info

Publication number
MA38162A1
MA38162A1 MA38162A MA38162A MA38162A1 MA 38162 A1 MA38162 A1 MA 38162A1 MA 38162 A MA38162 A MA 38162A MA 38162 A MA38162 A MA 38162A MA 38162 A1 MA38162 A1 MA 38162A1
Authority
MA
Morocco
Prior art keywords
sodium dihydrate
ibuprofen sodium
drug
lozenge based
drug lozenge
Prior art date
Application number
MA38162A
Other languages
English (en)
Other versions
MA38162B1 (fr
Inventor
Jean-François Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA38162(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MA38162A1 publication Critical patent/MA38162A1/fr
Publication of MA38162B1 publication Critical patent/MA38162B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet des pastilles médicamenteuses à sucer, de consistance solide pour se dissoudre dans la cavité buccale comprenant au moins l'ibuprofène sodique dihydraté comme principe actif, destinées au traitement des affections bucco-pharyngées.
MA38162A 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate MA38162B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (2)

Publication Number Publication Date
MA38162A1 true MA38162A1 (fr) 2016-12-30
MA38162B1 MA38162B1 (fr) 2019-12-31

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38162A MA38162B1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Country Status (17)

Country Link
US (1) US20160287514A1 (fr)
EP (1) EP2919752A1 (fr)
JP (1) JP6258342B2 (fr)
KR (1) KR20150084919A (fr)
CN (1) CN104780907A (fr)
AP (1) AP2015008515A0 (fr)
AU (1) AU2013346775B2 (fr)
BR (1) BR112015010808A2 (fr)
CA (1) CA2890832A1 (fr)
CL (1) CL2015001308A1 (fr)
FR (1) FR2997856B1 (fr)
MA (1) MA38162B1 (fr)
MX (1) MX2015006011A (fr)
RU (1) RU2015122217A (fr)
TN (1) TN2015000176A1 (fr)
WO (1) WO2014076203A1 (fr)
ZA (1) ZA201504280B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (fr) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Procédés de préparation de compositions curcuminoïdes
EP4017488A4 (fr) * 2019-08-22 2024-01-10 Applied Biological Laboratories, Inc. Compositions et procédés utilisant des médicaments anti-inflammatoires non stéroïdiens

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
MXPA06014185A (es) * 2004-06-07 2007-04-16 Strides Arcolab Ltd Composicion farmaceutica que contiene una solucion estable y clara de medicamento anti-inflmatorio en capsulas de gelatina blanda, y proceso para producirlo.
JP2008509207A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa, Inc. formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
US20070276042A1 (en) * 2006-05-26 2007-11-29 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
CL2015001308A1 (es) 2015-08-28
US20160287514A1 (en) 2016-10-06
FR2997856B1 (fr) 2015-04-24
AU2013346775B2 (en) 2018-06-28
WO2014076203A1 (fr) 2014-05-22
AP2015008515A0 (en) 2015-06-30
MX2015006011A (es) 2015-09-10
ZA201504280B (en) 2017-09-27
EP2919752A1 (fr) 2015-09-23
CA2890832A1 (fr) 2014-05-22
RU2015122217A (ru) 2017-01-10
JP2015537019A (ja) 2015-12-24
KR20150084919A (ko) 2015-07-22
CN104780907A (zh) 2015-07-15
JP6258342B2 (ja) 2018-01-10
FR2997856A1 (fr) 2014-05-16
TN2015000176A1 (fr) 2016-10-03
AU2013346775A1 (en) 2015-07-02
BR112015010808A2 (pt) 2017-07-11
MA38162B1 (fr) 2019-12-31

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
EP2868667A4 (fr) Agent thérapeutique à base d'anticorps anti-bmp9 en tant que principe actif, pour le traitement de l'anémie, notamment une anémie rénale et une anémie liée à un cancer
EP2418945A4 (fr) Compositions de sel minéral/acide sulfonique et procédés d'utilisation
EP3003285A4 (fr) Forme dosifiée pharmaceutique solide de libération d'au moins un principe pharmaceutique actif dans la cavité buccale
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201071144A1 (ru) Гетероциклические производные
EA201270216A1 (ru) Фармацевтический состав
MA33939B1 (fr) 5-alcynyl-pyrimidines
EP2279003A4 (fr) Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
EA201500245A1 (ru) Твердый фармацевтический препарат, который содержит левотироксин
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
EP2583972A4 (fr) Agent thérapeutique pour des maladies inflammatoires contenant de l'adénosine n1-oxyde en tant que principe actif
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
MA38162A1 (fr) Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
MA34946B1 (fr) Nouvelles benzodioxolepipérazines
UY30021A1 (es) Formulación de suspensión de fexofenadina
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
EA201100287A1 (ru) Композиция ропинирола
EA201492271A1 (ru) Соединения хроманов
EP2865380A4 (fr) Application de lactone a d'inula linariifolia dans une préparation de médicament destiné au traitement de la myocardite
EA201490573A1 (ru) Соединение бензотиазолона
ECSP15030460A (es) Composición de difenidol de liberación prolongada
AR077915A1 (es) Forma cristalina de pemirolast